Literature DB >> 6409064

The role of human salivary acidic proline-rich proteins in the formation of acquired dental pellicle in vivo and their fate after adsorption to the human enamel surface.

A Bennick, G Chau, R Goodlin, S Abrams, D Tustian, G Madapallimattam.   

Abstract

The pellicles formed on fragments of human dental enamel worn on a palatal appliance for 1 min to 24 h were removed by acid extraction and the total amounts of protein and of acidic proline-rich proteins were determined. The percentage of total extracted protein constituted by the proline-rich proteins increased during the first hour of formation to about 37 per cent. Little difference was seen in total proline-rich protein between pellicles formed in a 1 and a 24-h period, but there was a gradual degradation of the proteins. There was no preferential retention of the N- or C-terminal parts of the proteins. Extracts of old acquired dental pellicle contained less than 0.1 per cent proline-rich proteins and pellicles more than 24 h old showed degradation of the adsorbed proline-rich proteins; there is no indication that the N-terminal part which contains the known biological activities was retained to a greater extent than the C-terminal part.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409064     DOI: 10.1016/0003-9969(83)90022-5

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  24 in total

1.  Large-scale purification and characterization of the major phosphoproteins and mucins of human submandibular-sublingual saliva.

Authors:  N Ramasubbu; M S Reddy; E J Bergey; G G Haraszthy; S D Soni; M J Levine
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  Adherence of oral streptococci to salivary glycoproteins.

Authors:  P A Murray; A Prakobphol; T Lee; C I Hoover; S J Fisher
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Pellicle receptors for Actinomyces viscosus type 1 fimbriae in vitro.

Authors:  W B Clark; J E Beem; W E Nesbitt; J O Cisar; C C Tseng; M J Levine
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Asparagine-linked carbohydrate chains of inducible rat parotid proline-rich glycoprotein contain terminal beta-linked N-acetylgalactosamine.

Authors:  G S Bedi
Journal:  Glycoconj J       Date:  1997-12       Impact factor: 2.916

5.  The presence and origin of phosphopeptides in human saliva.

Authors:  K Minaguchi; G Madapallimattam; A Bennick
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

6.  Adsorbed salivary proline-rich protein 1 and statherin: receptors for type 1 fimbriae of Actinomyces viscosus T14V-J1 on apatitic surfaces.

Authors:  R J Gibbons; D I Hay; J O Cisar; W B Clark
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Effect of salivary pellicle on antibacterial activity of novel antibacterial dental adhesives using a dental plaque microcosm biofilm model.

Authors:  Fang Li; Michael D Weir; Ashraf F Fouad; Hockin H K Xu
Journal:  Dent Mater       Date:  2013-12-11       Impact factor: 5.304

8.  The primary structures of six human salivary acidic proline-rich proteins (PRP-1, PRP-2, PRP-3, PRP-4, PIF-s and PIF-f).

Authors:  D I Hay; A Bennick; D H Schlesinger; K Minaguchi; G Madapallimattam; S K Schluckebier
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

9.  High-resolution high-performance liquid chromatography with electrospray ionization mass spectrometry and tandem mass spectrometry characterization of a new isoform of human salivary acidic proline-rich proteins named Roma-Boston Ser₂₂ (Phos) → Phe variant.

Authors:  Federica Iavarone; Alfredo D'Alessandro; Na Tian; Tiziana Cabras; Irene Messana; Eva J Helmerhorst; Frank G Oppenheim; Massimo Castagnola
Journal:  J Sep Sci       Date:  2014-05-23       Impact factor: 3.645

10.  In vitro sorption of albumin, immunoglobulin G, and lysozyme to enamel and cementum from human teeth.

Authors:  D H Fine; J M Wilton; C Caravana
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.